Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05091346
Title A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Inc.
Indications

melanoma

hepatocellular carcinoma

colorectal cancer

Therapies

E7386 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.